| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0140-6736(07)60566-2 |
| P698 | PubMed publication ID | 17416264 |
| P50 | author | Lila Rahalison | Q115222163 |
| Michael B. Prentice | Q41463896 | ||
| P2860 | cites work | Genome sequence of Yersinia pestis KIM | Q22065462 |
| Complete Genome Sequence of Yersinia pestis Strains Antiqua and Nepal516: Evidence of Gene Reduction in an Emerging Pathogen | Q22065490 | ||
| A specific polysaccharide of Pasteurella pestis | Q41571318 | ||
| Primary pneumonic plague in Mukden, 1946, and report of 39 cases with three recoveries | Q41575798 | ||
| The PhoP/PhoQ system controls the intramacrophage type three secretion system of Salmonella enterica | Q44016971 | ||
| Safety precautions to limit exposure from plague-infected patients. | Q53734193 | ||
| Septic shock | Q81245367 | ||
| I. Experiments upon the transmission of plague by fleas: Part IV. Experiments in plague houses in Bombay | Q84233555 | ||
| Complete Genome Sequence of Yersinia pestis Strain 91001, an Isolate Avirulent to Humans | Q22066072 | ||
| Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis | Q22066387 | ||
| Genome sequence of Yersinia pestis, the causative agent of plague | Q22122371 | ||
| Detection of 400-year-old Yersinia pestis DNA in human dental pulp: an approach to the diagnosis of ancient septicemia | Q22248072 | ||
| Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes | Q24538942 | ||
| Microevolution and history of the plague bacillus, Yersinia pestis | Q24558763 | ||
| Genotyping, Orientalis-like Yersinia pestis, and plague pandemics | Q24604095 | ||
| Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis | Q24642708 | ||
| Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar | Q24646737 | ||
| Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation | Q24673773 | ||
| Molecular identification by "suicide PCR" of Yersinia pestis as the agent of medieval black death | Q24679324 | ||
| Structure and biogenesis of the capsular F1 antigen from Yersinia pestis: preserved folding energy drives fiber formation | Q27641384 | ||
| Evolutionary genetics: CCR5 mutation and plague protection | Q28244988 | ||
| Yersinia pestis--etiologic agent of plague | Q29619320 | ||
| Detection of Yersinia pestis DNA in two early medieval skeletal finds from Aschheim (Upper Bavaria, 6th century A.D.). | Q30343034 | ||
| Early-phase transmission of Yersinia pestis by unblocked fleas as a mechanism explaining rapidly spreading plague epizootics. | Q30357332 | ||
| Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature | Q30836915 | ||
| Variation in lipid A structure in the pathogenic yersiniae | Q31067117 | ||
| A Caenorhabditis elegans model of Yersinia infection: biofilm formation on a biotic surface. | Q33194563 | ||
| Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils | Q33225645 | ||
| Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis | Q33678428 | ||
| Structural organization of virulence-associated plasmids of Yersinia pestis. | Q33737468 | ||
| Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. | Q33750049 | ||
| Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection | Q33750739 | ||
| LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples. | Q33858962 | ||
| Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense | Q33901607 | ||
| LcrV plague vaccine with altered immunomodulatory properties | Q33946882 | ||
| Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania | Q33993221 | ||
| Yersinia pestis pFra shows biovar-specific differences and recent common ancestry with a Salmonella enterica serovar Typhi plasmid | Q33996045 | ||
| The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis | Q34004738 | ||
| Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector | Q34125533 | ||
| Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity | Q34201893 | ||
| Vaccination against bubonic and pneumonic plague | Q34310210 | ||
| Plague: a continuing threat | Q41458151 | ||
| Microarray analysis of temperature-induced transcriptome of Yersinia pestis | Q41460599 | ||
| Defining the genome content of live plague vaccines by use of whole-genome DNA microarray | Q41461622 | ||
| Evolutionary genetics: Ambiguous role of CCR5 in Y. pestis infection | Q41461835 | ||
| Transmission of Yersinia pestis from an infectious biofilm in the flea vector | Q41461840 | ||
| Absence of Yersinia pestis-specific DNA in human teeth from five European excavations of putative plague victims | Q41463890 | ||
| Retrospective study of a plague outbreak by multiplex-PCR. | Q41464796 | ||
| Development and testing of a rapid diagnostic test for bubonic and pneumonic plague | Q41469016 | ||
| Caenorhabditis elegans: plague bacteria biofilm blocks food intake | Q41471909 | ||
| Vector competence of Musca domestica (Diptera: Muscidae) for Yersinia pseudotuberculosis | Q41476187 | ||
| Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis | Q41476361 | ||
| An extended hydrophobic interactive surface of Yersinia pestis Caf1M chaperone is essential for subunit binding and F1 capsule assembly | Q41477423 | ||
| Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O: | Q41478664 | ||
| Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar | Q41480580 | ||
| Evaluation of the role of the Yersinia pestis plasminogen activator and other plasmid-encoded factors in temperature-dependent blockage of the flea | Q41484761 | ||
| Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine | Q41485426 | ||
| Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092. | Q41487542 | ||
| Multidrug resistance in Yersinia pestis mediated by a transferable plasmid | Q41487671 | ||
| Comparison of Yersinia CIN agar and mouse inoculation assay for the diagnosis of plague | Q41490211 | ||
| Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis | Q41494960 | ||
| Chromosomal irp2 gene in Yersinia: distribution, expression, deletion and impact on virulence | Q41504325 | ||
| A surface protease and the invasive character of plague | Q41504890 | ||
| Pasteurella pestis: Role of Pesticin I and Iron in Experimental Plague | Q41562748 | ||
| Role of the Yersinia pestis hemin storage (hms) locus in the transmission of plague by fleas | Q34384192 | ||
| Risk of person-to-person transmission of pneumonic plague | Q34406504 | ||
| Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague | Q34481674 | ||
| Yersinia pestis as a telluric, human ectoparasite-borne organism | Q34504283 | ||
| Administration of antibody to the lung protects mice against pneumonic plague. | Q34601788 | ||
| A plasminogen-activating protease specifically controls the development of primary pneumonic plague | Q34606584 | ||
| The Yersinia Ysc-Yop 'type III' weaponry | Q34931776 | ||
| Yersinia pestis and plague | Q35052944 | ||
| Evolution of pathogenic Yersinia, some lights in the dark | Q35131355 | ||
| Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen) | Q35159314 | ||
| Plague bacteria target immune cells during infection | Q35535438 | ||
| Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis | Q35546294 | ||
| The genome sequence of Yersinia pestis bacteriophage phiA1122 reveals an intimate history with the coliphage T3 and T7 genomes | Q35663061 | ||
| Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in new Mexico, 1985-1999. | Q35676396 | ||
| The recent emergence of plague: a process of felonious evolution | Q35706094 | ||
| The yersiniae--a model genus to study the rapid evolution of bacterial pathogens | Q35709112 | ||
| Intraspecific diversity of Yersinia pestis. | Q35745842 | ||
| Pneumonic plague cluster, Uganda, 2004 | Q35794004 | ||
| Epidemiologic determinants for modeling pneumonic plague outbreaks | Q35880203 | ||
| Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae | Q36049296 | ||
| First Report of the North Manchurian Plague Prevention Service | Q36312504 | ||
| Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression | Q36371199 | ||
| Identification of Yersinia pestis by BBL Crystal Enteric/Nonfermenter Identification System | Q36541704 | ||
| Factors promoting acute and chronic diseases caused by yersiniae | Q36637747 | ||
| Detection of Yersinia pestis in sputum by real-time PCR. | Q36891342 | ||
| New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas | Q37128144 | ||
| Temporal global changes in gene expression during temperature transition in Yersinia pestis | Q37494579 | ||
| The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence | Q37521683 | ||
| Metapopulation dynamics of bubonic plague | Q39550991 | ||
| Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. | Q39573935 | ||
| Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis | Q39654111 | ||
| Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice | Q40756138 | ||
| Septicemic plague in New Mexico | Q40800431 | ||
| Biological weapons control. Prospects and implications for the future | Q40883813 | ||
| Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. | Q41142448 | ||
| Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection | Q41453869 | ||
| Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. | Q41454706 | ||
| Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague | Q41455673 | ||
| P433 | issue | 9568 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1196-1207 | |
| 1196-207 | |||
| P577 | publication date | 2007-04-01 | |
| 2007-04-07 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Plague | |
| P478 | volume | 369 |
| Q35028538 | A comprehensive study on the role of the Yersinia pestis virulence markers in an animal model of pneumonic plague. |
| Q34778198 | A live attenuated strain of Yersinia pestis KIM as a vaccine against plague |
| Q41334344 | A multicopy suppressor screening approach as a means to identify antibiotic resistance determinant candidates in Yersinia pestis |
| Q37033054 | A novel autotransporter adhesin is required for efficient colonization during bubonic plague |
| Q35996096 | A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis |
| Q37217053 | Acute respiratory infections in a recently arrived traveler to your part of the world |
| Q37145022 | Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge |
| Q35418294 | Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges |
| Q37943429 | Animal-related fatalities--part II: characteristic autopsy findings and variable causes of death associated with envenomation, poisoning, anaphylaxis, asphyxiation, and sepsis |
| Q41441607 | Antibodies and cytokines independently protect against pneumonic plague. |
| Q42716457 | Arbobacteria - Pathogens Transmittable by Arthropods |
| Q42472763 | Arbobacteria – Pathogens Transmittable by Arthropods |
| Q34349999 | Bioluminescence imaging to track bacterial dissemination of Yersinia pestis using different routes of infection in mice |
| Q38119683 | Biowarfare and bioterrorism. |
| Q33500145 | CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells |
| Q33995202 | Characterization of Borrelia burgdorferi aggregates |
| Q31107998 | Climate Change and Respiratory Infections |
| Q47721065 | Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics. |
| Q35187610 | Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague |
| Q35949994 | Comparative analysis of the regulation of rovA from the pathogenic yersiniae |
| Q38391659 | Controlling Ebola: what we can learn from China's 1911 battle against the pneumonic plague in Manchuria |
| Q36628038 | Current challenges in the development of vaccines for pneumonic plague |
| Q30573867 | Cytotoxic necrotizing factor-Y boosts Yersinia effector translocation by activating Rac protein |
| Q99569132 | Deaths Associated with Pneumonic Plague, 1946-2017 |
| Q33321253 | Defective innate cell response and lymph node infiltration specify Yersinia pestis infection |
| Q33603015 | Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague |
| Q35077622 | Detection of chronic wasting disease prions in salivary, urinary, and intestinal tissues of deer: potential mechanisms of prion shedding and transmission |
| Q34490407 | Dioxygenases in Burkholderia ambifaria and Yersinia pestis that hydroxylate the outer Kdo unit of lipopolysaccharide |
| Q33601814 | Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV |
| Q27321792 | Dissemination of a highly virulent pathogen: tracking the early events that define infection |
| Q35814177 | Dissociation of Tissue Destruction and Bacterial Expansion during Bubonic Plague. |
| Q36958086 | Divergence among genes encoding the elongation factor Tu of Yersinia Species. |
| Q38279676 | Ebola virus disease: a highly fatal infectious disease reemerging in West Africa. |
| Q33557913 | Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis |
| Q33942640 | Efficacy of primate humoral passive transfer in a murine model of pneumonic plague is mouse strain-dependent. |
| Q51814475 | Epidemiological analysis of the Eyam plague outbreak of 1665-1666. |
| Q34075392 | Evaluation of up-converting phosphor technology-based lateral flow strips for rapid detection of Bacillus anthracis Spore, Brucella spp., and Yersinia pestis |
| Q36277319 | Evolution and virulence contributions of the autotransporter proteins YapJ and YapK of Yersinia pestis CO92 and their homologs in Y. pseudotuberculosis IP32953 |
| Q36725704 | Experimental evidence for negative selection in the evolution of a Yersinia pestis pseudogene |
| Q28392533 | Extraction of Aerosol-Deposited Yersinia pestis from Indoor Surfaces To Determine Bacterial Environmental Decay |
| Q34785412 | Features of Variable Number of Tandem Repeats in Yersinia pestis and the Development of a Hierarchical Genotyping Scheme |
| Q35010618 | Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis). |
| Q30386274 | Genome rearrangements of completely sequenced strains of Yersinia pestis. |
| Q36970746 | Geographic distribution and ecological niche of plague in sub-Saharan Africa |
| Q34633478 | HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model |
| Q64954371 | Historical and genomic data reveal the influencing factors on global transmission velocity of plague during the Third Pandemic. |
| Q99730735 | History of the Plague: An Ancient Pandemic for the Age of Covid-19 |
| Q64092755 | Human Macrophages Clear the Biovar Microtus Strain of More Efficiently Than Murine Macrophages |
| Q91941246 | Human plague system associated with rodent diversity and other environmental factors |
| Q46463260 | Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis |
| Q34562642 | Identification of novel protein-protein interactions of Yersinia pestis type III secretion system by yeast two hybrid system |
| Q33584403 | Immune defense against pneumonic plague |
| Q37264991 | Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial |
| Q83042711 | Intracellular pathogenic bacteria and fungi--a case of convergent evolution? |
| Q40485593 | Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague |
| Q36911486 | Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection |
| Q30157319 | Invited review: Breaking barriers--attack on innate immune defences by omptin surface proteases of enterobacterial pathogens. |
| Q41355611 | Knowledge and practices related to plague in an endemic area of Uganda |
| Q34298699 | LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague |
| Q36296540 | Mechanism study on a plague outbreak driven by the construction of a large reservoir in southwest china (surveillance from 2000-2015) |
| Q37150318 | Microenvironmental impact on lung cell homeostasis and immunity during infection |
| Q40969023 | Molecualr Cloning of the capsular antigen F1 of Yersinia pestis in pBAD/gIII plasmid |
| Q35986316 | New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria |
| Q89176393 | One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study |
| Q36372952 | Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague |
| Q41432976 | Outbreak of gastroenteritis caused by Yersinia pestis in Afghanistan |
| Q40548407 | Pathology and Pathogenesis of Yersinia pestis |
| Q38849193 | Patterns of Human Plague in Uganda, 2008-2016. |
| Q69959825 | Phylogeography of the second plague pandemic revealed through analysis of historical Yersinia pestis genomes |
| Q34031178 | Plague and climate: scales matter |
| Q34766917 | Plague circulation and population genetics of the reservoir Rattus rattus: the influence of topographic relief on the distribution of the disease within the Madagascan focus |
| Q41395587 | Plague detection by anti-carbohydrate antibodies |
| Q40512127 | Plague: A Disease Which Changed the Path of Human Civilization |
| Q38976954 | Plague: Clinics, Diagnosis and Treatment |
| Q50085285 | Plague: Recognition, Treatment, and Prevention |
| Q26783107 | Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents |
| Q46493128 | Pneumonia in the tropics: Report from the Task Force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine |
| Q64059044 | Predatory bacteria can protect SKH-1 mice from a lethal plague challenge |
| Q33398933 | Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. |
| Q33487545 | Protection against anthrax and plague by a combined vaccine in mice and rabbits |
| Q36099515 | Protection against pneumonic plague following oral immunization with a non-replicating vaccine |
| Q34123275 | Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid |
| Q33801976 | Pulmonary infections in the returned traveller. |
| Q41434206 | Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras |
| Q27664944 | Rational Design, Synthesis, and Evaluation of New Selective Inhibitors of Microbial Class II (Zinc Dependent) Fructose Bis-phosphate Aldolases |
| Q37688618 | Rational considerations about development of live attenuated Yersinia pestis vaccines |
| Q38059898 | Real-time PCR as a diagnostic tool for bacterial diseases |
| Q37081655 | Regulation of whole bacterial pathogen transcription within infected hosts |
| Q41432988 | Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice |
| Q92644859 | Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague |
| Q49956044 | Strain discrimination of Yersinia pestis using a SERS-based electrochemically driven melting curve analysis of variable number tandem repeat sequences |
| Q84446170 | Suppurative lymphadenitis |
| Q41434176 | Susceptibility to Yersinia pestis experimental infection in wild Rattus rattus, reservoir of plague in Madagascar |
| Q37371363 | Synthesis and in vitro Efficacy Studies of Silver Carbene Complexes on Biosafety Level 3 Bacteria |
| Q34380204 | TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. |
| Q41432452 | Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. |
| Q38813140 | Taxonomy of Yersinia pestis |
| Q87897334 | The Great Transition: Climate, disease and society in the late-medieval world |
| Q35867730 | The Yersinia pestis Rcs phosphorelay inhibits biofilm formation by repressing transcription of the diguanylate cyclase gene hmsT. |
| Q34529535 | The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background |
| Q27010109 | The mycetoma knowledge gap: identification of research priorities |
| Q41441178 | The response regulator PhoP negatively regulates Yersinia pseudotuberculosis and Yersinia pestis biofilms |
| Q33429039 | The role of environmental transmission in recurrent avian influenza epidemics |
| Q33675834 | The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection |
| Q50983858 | The trophic responses of two different rodent-vector-plague systems to climate change. |
| Q64121955 | Transcriptomic studies and assessment of Yersinia pestis reference genes in various conditions |
| Q30224792 | Treatment of neuroterrorism |
| Q36218535 | Two Isoforms of Yersinia pestis Plasminogen Activator Pla: Intraspecies Distribution, Intrinsic Disorder Propensity, and Contribution to Virulence |
| Q37867011 | Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches |
| Q31148145 | Two-step source tracing strategy of Yersinia pestis and its historical epidemiology in a specific region |
| Q40026758 | Use of a public telephone hotline to detect urban plague cases |
| Q36950063 | Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis |
| Q58544318 | Vectors, Bites, and Venoms: Articles on Insects and Other Arthropods of Medical Importance. Which Journals Published the Most and on Which Insects, 2007–2011? |
| Q34257405 | Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector |
| Q34398644 | Whole-Genome Yersinia sp. Assemblies from 10 Diverse Strains |
| Q39887644 | Yersinia pestis and host macrophages: immunodeficiency of mouse macrophages induced by YscW. |
| Q41439631 | Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification |
| Q38949582 | Yersinia protein kinase A phosphorylates vasodilator-stimulated phosphoprotein to modify the host cytoskeleton |
| Q26747057 | Yersinia virulence factors - a sophisticated arsenal for combating host defences |
| Q21146740 | YersiniaBase: a genomic resource and analysis platform for comparative analysis of Yersinia |
| Q33521195 | Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells |
Search more.